Provided is a pre-filled drug package that can inhibit protein aggregation after long-term storage even when accommodating a protein solution formulation having a low non-ionic surfactant concentration. The pre-filled drug package includes a protein solution formulation and a housing accommodating the protein solution formulation. The protein solution formulation has a non-ionic surfactant concentration of not less than 0 mg/mL and less than 0.05 mg/mL. At least part of a section of the housing that is in contact with the protein solution formulation is formed of a resin including either or both of a hydrogenated cycloolefin ring-opened polymer and a copolymer of a cycloolefin and a chain olefin.

Provided is a pre-filled drug package that can inhibit protein aggregation after long-term storage even when accommodating a protein solution formulation having a low non-ionic surfactant concentration. The pre-filled drug package includes a protein solution formulation and a housing accommodating the protein solution formulation. The protein solution formulation has a non-ionic surfactant concentration of not less than 0 mg/mL and less than 0.05 mg/mL. At least part of a section of the housing that is in contact with the protein solution formulation is formed of a resin including either or both of a hydrogenated cycloolefin ring-opened polymer and a copolymer of a cycloolefin and a chain olefin.

A therapeutic pouch is provided. The therapeutic pouch defines a cavity for slidably receiving intravenous therapy equipment, such as an IV bag or other fluid dispenser. A front portion of the therapeutic pouch provides a comforting presentation for the patient, while the rear portion of the therapeutic pouch provides a visibility pouch for securing the IV bag and allowing a healthcare provider visibility of the administration of the fluids retained by the IV bag. The visibility pouch may provide an upper opening and an opposing lower opening, both communicating with the cavity for enabling the IV bag to protrude therefrom and access to IV tubing and ports, respectively. An upper portion of the therapeutic pouch provides a hanging loop for working in unison with the IV bag hole for enabling support from an IV stand or the like.

A therapeutic pouch is provided. The therapeutic pouch defines a cavity for slidably receiving intravenous therapy equipment, such as an IV bag or other fluid dispenser. A front portion of the therapeutic pouch provides a comforting presentation for the patient, while the rear portion of the therapeutic pouch provides a visibility pouch for securing the IV bag and allowing a healthcare provider visibility of the administration of the fluids retained by the IV bag. The visibility pouch may provide an upper opening and an opposing lower opening, both communicating with the cavity for enabling the IV bag to protrude therefrom and access to IV tubing and ports, respectively. An upper portion of the therapeutic pouch provides a hanging loop for working in unison with the IV bag hole for enabling support from an IV stand or the like.

A biopharmaceutical flow port, a biopharmaceutical liquid container assembly, and a method for manufacturing the biopharmaceutical flow port and the biopharmaceutical liquid container assembly are described. The biopharmaceutical flow port includes a hose barb coupled to an elliptic body. The hose barb includes a bore. The elliptic body includes a flow passage, a first edge, and a second edge. The flow passage is fluidly coupled to the bore. The first edge extends from the elliptic body away from the flow passage in a first direction and the second edge extends from the elliptic body away from the flow passage in a second direction opposite the first direction. The biopharmaceutical liquid container assembly includes a biopharmaceutical liquid container with an opening and the biopharmaceutical flow port coupled to the biopharmaceutical liquid container within the opening and in fluid communication with a volume of the biopharmaceutical liquid container.

A kit preparation that enables drug dose adjustment. The kit preparation includes a bag which contains an infusion solution or pure water and at least one drug enclosing part in which a drug is enclosed and which is provided with a sealing part. The drug enclosing part is connected to the bag via the sealing part; and, when the sealing part is released, the bag is communicated with the drug enclosing part and thus the drug is poured into the bag so that a dispensing work can be carried out.

A kit preparation that enables drug dose adjustment. The kit preparation includes a bag which contains an infusion solution or pure water and at least one drug enclosing part in which a drug is enclosed and which is provided with a sealing part. The drug enclosing part is connected to the bag via the sealing part; and, when the sealing part is released, the bag is communicated with the drug enclosing part and thus the drug is poured into the bag so that a dispensing work can be carried out.

The present invention relates to a medical device having a transparent region and a label wherein a hot stamping film is located on the transparent region; and a thermal transfer film that in turn has a label is located on the hot stamping film, with the label having a different color than the hot stamping film. The invention furthermore relates to a method of applying a label to a medical device.

The present invention relates to a medical device having a transparent region and a label wherein a hot stamping film is located on the transparent region; and a thermal transfer film that in turn has a label is located on the hot stamping film, with the label having a different color than the hot stamping film. The invention furthermore relates to a method of applying a label to a medical device.

A freeze/thaw containment system is provided, having a protecting body and a flexible pouch, of a first capacity, protected by two plates of the protecting body. The two plates are attached together at a peripheral margin and form a rectangular protecting body. The peripheral margin is mounted in a stationary frame and allowed to be displaced inwardly during filling of the pouch, while the protecting body extends generally planar to sandwich and constrain the pouch. One amongst the stationary frame and the protecting body includes fastening members for attachment of a casing configured for storing the bag, in order to have the bag fastened parallel to the protecting body. Two fasteners for cooperating with the fastening members are distributed around a bag containing part of a second capacity at least ten times inferior to the first capacity. Same biopharmaceutical composition is contained in the pouch and in the bag.